Product Program year 2025 Source: CMS Open Payments

Ultraverse 014

Device Vascular/Oncology

PDI 00801741053962

Open in the dashboard

General payments

$4,035

156 payments

Research payments

$0

0 payments

Through program year 2025, $4,035 in general payments and $0 in research payments were reported against Ultraverse 014 (Vascular/Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $851 58
2024 General $2,642 60
2023 General $542 38

Breakdown

Who paid General payments · program years 2023–2025
  1. Bard Peripheral Vascular, Inc. $3,412 115 payments
  2. Becton, Dickinson and Company $623 41 payments
Top recipients General payments · program year 2025
  1. Surrender Raina Cardiovascular Disease · Stockton, CA $205 24% · 24 payments
  2. Elizabeth Phung-Hart Internal Medicine · Las Vegas, NV $61 7% · 5 payments
  3. Feliciano Serrano Nephrology · Huntington Park, CA $58 7% · 2 payments
  4. Harold Tabaie Thoracic Surgery (Cardiothoracic Vascular Surgery) · Los Angeles, CA $51 6% · 3 payments
  5. Marc Hare Emergency Medicine · La Jolla, CA $37 4% · 1 payment

The top 5 of 25 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Cardiovascular Disease Internal Medicine $220 26% · 2 practitioners
  2. Vascular Surgery Surgery $143 17% · 6 practitioners
  3. Thoracic Surgery (Cardiothoracic Vascular Surgery) $81 10% · 2 practitioners
  4. Internal Medicine $61 7% · 1 practitioner
  5. Nephrology Internal Medicine $58 7% · 1 practitioner

The top 5 of 15 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $699 82% · 18 recipients
  2. New York $38 4% · 2 recipients
  3. Illinois $37 4% · 1 recipient
  4. Hawaii $28 3% · 1 recipient
  5. Oregon $23 3% · 1 recipient

The top 5 of 7 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

156 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record